Variable expression of human beta defensins 3 and 9 at the human ocular surface in infectious keratitis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 2, 2012, Pages 757-761

  Otri, Ahmad Muneer ^a,b   Mohammed, Imran ^a   Al Aqaba, Mouhamed A ^a   Fares, Usama ^a   Peng, Chen ^a   Hopkinson, Andrew ^a   Dua, Harminder S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Aleppo University Hospital   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 3; BETA DEFENSIN 9; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN 3, HUMAN; BETA-DEFENSIN 3, HUMAN; DEFB 109 PEPTIDE, HUMAN; DEFB-109 PEPTIDE, HUMAN; MESSENGER RNA;

ACANTHAMOEBA KERATITIS; ARTICLE; BACTERIAL KERATITIS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; DOWN REGULATION; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; IMPRESSION CYTOLOGY; KERATITIS; KLEBSIELLA; MORAXELLA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UPREGULATION; BACTERIAL EYE INFECTION; BIOSYNTHESIS; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CORNEA; DIAGNOSIS, DIFFERENTIAL; EYE INFECTIONS, BACTERIAL; GENE EXPRESSION REGULATION; HUMANS; KERATITIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84858957826     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8467     Document Type: Article

References (25)

1. Willcox MD, Holden BA. Contact lens related corneal infections. Biosci Rep. 2001;21:445-461.
2. Willcox MD. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci. 2007;84: 273-278.
3. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148:487-499, e482.
4. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009; 30:131-141.
5. Sack RA, Nunes I, Beaton A, Morris C. Host-defense mechanism of the ocular surfaces. Biosci Rep. 2001;21:463-480.
6. McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci. 2005;46:1379-1385.
7. Abedin A, Mohammed I, Hopkinson A, Dua HS. A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Invest Ophthalmol Vis Sci. 2008;49: 28-33.
8. Mohammed I, Yeung A, Abedin A, Hopkinson A, Dua HS. Signalling pathways involved in ribonuclease-7 expression. Cell Mol Life Sci. 2010;68:1941-1952.
9. McDermott AM. The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 2009;41:60-75.
10. Huang LC, Jean D, Proske RJ, Reins RY, McDermott AM. Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res. 2007;32:595-609.
11. Mohammed I, Suleman H, Otri AM, et al. Localization and gene expression of human beta-defensin 9 at the human ocular surface epithelium. Invest Ophthalmol Vis Sci. 2010;51:4677-4682.
12. Otri AM, Mohammed I, Abedin A, et al. Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii: an in vitro study. Br J Ophthalmol. 2010;94:1523-1527.
13. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001;276:5707-5713.
14. Alomar T, Matthew M, Donald F, Maharajan S, Dua HS. In vivo confocal microscopy in the diagnosis and management of acanthamoeba keratitis showing new cystic forms. Clin Exp Ophthalmol. 2009;37:737-739.
15. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf. 2004;2:229-247.
16. Garreis F, Schlorf T, Worlitzsch D, et al. Roles of human betadefensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol. 2010;134:59-73.
17. McDermott AM, Rich D, Cullor J, et al. The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears. Br J Ophthalmol. 2006;90:609-611.
18. Yuan X, Hua X, Wilhelmus KR. The corneal expression of antimicrobial peptides during experimental fungal keratitis. Curr Eye Res. 2010;35:872-879.
19. Feldman ST, Speaker M, Cleveland P. Effect of magainins on Acanthamoeba castellanii. Rev Infect Dis. 1991;13(suppl 5):S439.
20. Schuster FL, Jacob LS. Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga. Antimicrob Agents Chemother. 1992;36:1263-1271.
21. Sacramento RS, Martins RM, Miranda A, et al. Differential effects of alpha-helical and beta-hairpin antimicrobial peptides against Acanthamoeba castellanii. Parasitology. 2009;136:813-821.
22. Clarke DW, Niederkorn JY. The immunobiology of Acanthamoeba keratitis. Microbes Infect. 2006;8:1400-1405.
23. Na BK, JH, Song CY, Kim TS. Degradation of immunoglobulins, protease inhibitors and interleukin-1 by a secretory proteinase of Acanthamoeba castellanii. Korean J Parasitol. 2002;40:93-99.
24. Premratanachai P, Joly S, Johnson GK, McCray PB Jr, Jia HP, Guthmiller JM. Expression and regulation of novel human betadefensins in gingival keratinocytes. Oral Microbiol Immunol. 2004;19:111-117.
25. Ikeda A, Nakanishi Y, Sakimoto T, Shoji J, Sawa M, Nemoto N. Expression of beta defensins in ocular surface tissue of experimentally developed allergic conjunctivitis mouse model. Jpn J Ophthalmol. 2006;50:1-6.